Rosana Kapeller rais­es $77M in bid to make re­peatome drugs a re­al­i­ty

Giv­en the choice, Rosana Kapeller would have picked dif­fer­ent cir­cum­stances to be a first time founder-CEO.

The long­time com­pu­ta­tion­al bi­ol­o­gist, an ear­ly vet­er­an of Mil­len­ni­um …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER